News

Researchers funded by Prostate Cancer UK and the Medical Research Council (MRC) have taken a crucial step forward by identifying a gene that’s potentially instrumental to the growth of both the prostate gland and prostate tumours. Scientists believe this discovery – published today in ‘PLOS ONE’ - could lead to improvements in prostate cancer diagnosis and treatment in the future.

Prostate Cancer UK (formerly The Prostate Cancer Charity) has renewed its call for the breakthrough prostate cancer drug abiraterone to be made available on the NHS in Scotland.

Prostate Cancer UK (formerly The Prostate Cancer Charity) has welcomed news that The Department of Health, Social Services and Public Safety has recommend abiraterone – the breakthrough treatment for men with incurable prostate cancer – for use on the NHS in Northern Ireland.